The HepatoPancreaticoBiliary Resection Arginine Immunomodulation (PRIMe) Trial

NCT04549662 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sunnybrook Health Sciences Centre

Collaborators